| Autor: |
Rahimi Kahmini A; Department of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, Florida, United States., Valera IC; Department of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, Florida, United States., Crawford RQ; Department of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, Florida, United States., Samarah L; Department of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, Florida, United States., Reis G; Department of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, Florida, United States., Elsheikh S; Department of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, Florida, United States., Kanashiro-Takeuchi RM; Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, Florida, United States.; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida, United States., Mohammadipoor N; Department of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, Florida, United States., Olateju BS; Department of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, Florida, United States., Matthews AR; Department of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, Florida, United States., Parvatiyar MS; Department of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, Florida, United States. |
| Abstrakt: |
Numerous genes including sarcospan (SSPN) have been designated as obesity-susceptibility genes by human genome-wide association studies. Variants in the SSPN locus have been linked with sex-dependent obesity-associated traits; however, this association has not been investigated in vivo. To delineate the role SSPN plays in regulating metabolism with potential to impact cardiac function, we subjected young and aged global SSPN-deficient (SSPN -/- ) male and female mice to obesogenic conditions (60% fat diet). We hypothesized that loss of SSPN combined with metabolic stress would increase susceptibility of mice to cardiometabolic disease. Baseline and end-point assessments of several anthropometric parameters were performed including weight, glucose tolerance, and fat distribution of mice fed control (CD) and high-fat (HFD) diet. Doppler echocardiography was used to monitor cardiac function. White adipose and cardiac tissues were assessed for inflammation by histological, gene expression, and cytokine analysis. Overall, SSPN deficiency protected both sexes and ages from diet-induced obesity, with a greater effect in females. SSPN -/- HFD mice gained less weight than wild-type (WT) cohorts, while SSPN -/- CD groups increased weight. Furthermore, aged SSPN -/- mice developed glucose intolerance regardless of diet. Echocardiography showed preserved systolic function for all groups; however, aged SSPN -/- males exhibited significant increases in left ventricular mass (CD) and signs of diastolic dysfunction (HFD). Cytokine analysis revealed significantly increased IL-1α and IL-17Α in white adipose tissue from young SSPN -/- male mice, which may be protective from diet-induced obesity. Overall, these studies suggest that several sex-dependent mechanisms influence the role SSPN plays in metabolic responses that become evident with age. NEW & NOTEWORTHY Young and aged sarcospan (SSPN)-deficient mice were examined to assess the role of SSPN in obesity and cardiometabolic disease. Both sexes displayed a "leaner" phenotype in response to high-fat diet (HFD). Notably, several sex differences were identified in aged SSPN-deficient mice: 1 ) females developed glucose intolerance (control and HFD) and 2 ) males exhibited increased left ventricular mass (control) and diastolic dysfunction (HFD). Therefore, we conclude that SSPN exerts a sex-dependent influence on obesity-associated diseases. |
